Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q1 2025 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2025-05-15

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $111M (100.0% shares, 0.0% debt)

Holdings (5)

PHVS Pharvaris N.V. 62.3%

Value $69.25M Shares 4,410,581 Est. Cost $27.29 Unrealized -38.2%

MAZE Maze Therapeutics Inc 20.9%

Value $23.25M Shares 2,111,919 Est. Cost $12.04 Unrealized 0.0%

— Lyell Immunopharma, Inc. 7.8%

Value $8.612M Shares 16,007,999 Est. Cost $8.70 Unrealized —

KURA Kura Oncology, Inc. 6.6%

Value $7.338M Shares 1,111,882 Est. Cost $20.39 Unrealized -61.8%

RLAY Relay Therapeutics Inc. 2.4%

Value $2.62M Shares 1,000,000 Est. Cost $7.47 Unrealized -47.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	Pharvaris N.V.	4,410,581	$69.25M	62.3%	$27.29	-38.2%	COM	N69605108
MAZE	Maze Therapeutics Inc	2,111,919	$23.25M	20.9%	$12.04	0.0%	COM	578784100
—	Lyell Immunopharma, Inc.	16,007,999	$8.612M	7.8%	$8.70	—	COM	55083R104
KURA	Kura Oncology, Inc.	1,111,882	$7.338M	6.6%	$20.39	-61.8%	COM	50127T109
RLAY	Relay Therapeutics Inc.	1,000,000	$2.62M	2.4%	$7.47	-47.6%	COM	75943R102